Get the Stockscreener App
8.82
1.15%
0.10
Robostrategy Inc stock is traded at $8.82, with a volume of 186.05K.
It is up +1.15% in the last 24 hours and up +18.55% over the past month.
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
See More
Previous Close:
$8.72
Open:
$8.75
24h Volume:
186.05K
Relative Volume:
0.43
Market Cap:
$706.54M
Revenue:
-
Net Income/Loss:
$-124.74M
P/E Ratio:
-0.0167
EPS:
-527.5896
Net Cash Flow:
$-149.71M
1W Performance:
+3.04%
1M Performance:
+18.55%
6M Performance:
-30.11%
1Y Performance:
+0.00%
1-Day Range:
$8.41
$8.95
1-Week Range:
$8.27
$9.36
52-Week Range:
$7.00
$14.87
Robostrategy Inc Stock (BBOT) Company Profile
Name
Robostrategy Inc
Sector
Industry
Phone
857 702 0377
Address
256 E. GRAND AVENUE, SUITE 104, SOUTH SAN FRANCISCO
Compare BBOT vs DNP, UTG, ADX, UTF, AADX
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BBOT
Robostrategy Inc
|
8.82 | 706.54M | 0 | -124.74M | -149.71M | -527.59 |
DNP
Dnp Select Income Fund Inc
|
11.10 | 4.18B | 0 | 0 | 0 | 0.00 |
UTG
Reaves Utility Income Fund
|
40.04 | 3.69B | 0 | 0 | 0 | 0.00 |
ADX
Adams Diversified Equity Fund
|
25.88 | 3.17B | 0 | 0 | 0 | 0.00 |
UTF
Cohen Steers Infrastructure Fund Inc
|
28.07 | 3.14B | 0 | 0 | 0 | 0.00 |
AADX
Adams Diversified Equity Fund
|
18.01 | 3.08B | 522.09M | -24.84M | 0 | -0.1455 |
Robostrategy Inc Stock (BBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-26 | Initiated | Stifel | Buy |
| Jan-09-26 | Initiated | Raymond James | Outperform |
| Dec-05-25 | Initiated | Morgan Stanley | Overweight |
| Sep-17-25 | Initiated | Leerink Partners | Outperform |
| Sep-15-25 | Initiated | H.C. Wainwright | Buy |
| Aug-15-25 | Initiated | Piper Sandler | Overweight |
View All
Robostrategy Inc Stock (BBOT) Latest News
RoboStrategy, Inc. Revenue Breakdown – MUN:S0I - TradingView
Wei Yen Yeh Net Worth (2026) - GuruFocus
James Michael Fields Net Worth (2026) - GuruFocus
BOT Price Today: RoboStrategy, Inc. Stock Price, Quote & Chart - MEXC
Robert Lance Baker Net Worth (2026) - GuruFocus
Fp Strategies Llc Net Worth (2026) - GuruFocus
After tax other income/expense of RoboStrategy, Inc. – HAM:S0I - TradingView
RoboStrategy Tokenized Stock Price: Live BOT/USD Rate, Market Cap & BOT Price Chart - CoinCodex
RoboStrategy(BOT) Stock Options Chain | Quotes & News - Moomoo
Revenue per share of RoboStrategy, Inc. – GETTEX:S0I - TradingView
$BOT Stock Is Down 9% Today. Here's What We See in Our Data. - Moomoo
Non-controlling/minority interest of RoboStrategy, Inc. – HAM:S0I - TradingView
RoboStrategy (BOT) Stock Forum and Discussion - Moomoo
BOT SEC FilingsRoboStrategy Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Net current asset value per share of RoboStrategy, Inc. – TRADEGATE:S0I - TradingView
Price to earnings forward of RoboStrategy, Inc. – MUN:S0I - TradingView
RoboStrategy, Inc. SEC Filing (Jul 17, 2026) - Stock Titan
RoboStrategy (BOT) sets up $2B equity line and 14.1M-share resale - Stock Titan
RoboStrategy, Inc. (BOT) affiliate transfers 50,000 shares to employee - Stock Titan
RoboStrategy(BOT.US) 10% Shareholder Buys US$10 Million in Common Stock - Moomoo
Price to earnings forward of RoboStrategy, Inc. – GETTEX:S0I - TradingView
Robostrategy Insider Bought Shares Worth $9,999,988, According to a Recent SEC Filing - Moomoo
50,000 RoboStrategy (BOT) shares transferred under COO’s indirect holdings - Stock Titan
RoboStrategy, Inc. (BOT) chief buys 272,405 shares at $36.71 - Stock Titan
RoboStrategy raises $16 million in private share placement By Investing.com - Investing.com South Africa
RoboStrategy Earnings Date, Reports & Earnings Call - Moomoo
RoboStrategy raises $16 million in private share placement - Investing.com UK
RoboStrategy (BOT) sells $20,000,018 in pooled investment fund interests - Stock Titan
RoboStrategy, Inc. Raises Approximately $16.0 Million Through Private Share Issuances, Including $10.0 Million Investment by CEO Andrew Kang - The Manila Times
RoboStrategy Raises $16 Million in Private Placements Led by CEO's $10 Million Investment - citybiz
RoboStrategy, Inc. Raises $16.0 Million in Private Share Issuances, Including $10.0 Million Investment by CEO Andrew Kang - Moomoo
Press Release: RoboStrategy, Inc. Raises Approximately $16.0 Million Through Private Share Issuances, Including $10.0 Million Investment by CEO Andrew Kang - 富途牛牛
RoboStrategy (BOT) Income Statement & Earnings - Moomoo
Bitget 上线 BOT、INTW 等 4 只股票永续合约 - CryptoRank
Pionex expands offering with BOTX (RoboStrategy) and EWTX (iShares MSCI Taiwan ETF) - Traders Union
RoboStrategy raises $16M in private share issuances; CEO invests $10M - MSN
BBOT Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Market ResponseLong-Term Guidance - dars.gov.et
BridgeBio Oncology Therapeutics: KRAS Program Data Due 2H26 May Reignite Bullish Sentiment - Seeking Alpha
RoboStrategy Inc (Derivatives): Latest News, Social Media Updates and Insights - CryptoRank
KuCoin Futures Will List BOTUSDT, KSTRUSDT & SNXXUSDT Stock Index Perpetual Contracts (2026-07-10) - KuCoin
BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Trading Down 7.9%Should You Sell? - MarketBeat
RoboStrategy (BOT) sells $87.9M in pooled fund interests under Rule 506(b) - Stock Titan
symbol__ Stock Quote Price and Forecast - CNN
BBOT Stock Price, Quote & Chart - ChartMill
BBOT Initiated Coverage by JP Morgan -- Rating Set to Overweight - GuruFocus
RoboStrategy reports 17.8% NAV increase, raises $7.6M - Investing.com
RoboStrategy reports 17.8% NAV increase, raises $7.6M By Investing.com - Investing.com Nigeria
RoboStrategy, Inc. Announces Updated Net Asset Value and Additional Private Placements - The Manila Times
RoboStrategy, Inc. Reports June 30 NAV Increase and Completes $7.6 Million in Private Share Issuances - Moomoo
BBOT Q1 2026 Earnings: Pre-Revenue Oncology Biotech Reports Narrower-than-Expected Loss - dars.gov.et
JPMorgan initiates BridgeBio Oncology stock with overweight rating By Investing.com - Investing.com Nigeria
Robostrategy Inc Stock (BBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.68%
0.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):